Skip to main content
SpringerLink
Log in

Alemtuzumab/interferon-beta-1a/methylprednisolone

Primary central nervous system vasculitis and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Varela L, et al. Primary Central Nervous System Vasculitis Following Alemtuzumab Treatment for Multiple Sclerosis: A Case Report and Literature Review. Neurologist 28 : 270-272, No. 4, Jul 2023. Available from: URL: http://doi.org/10.1097/NRL.0000000000000480

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab/interferon-beta-1a/methylprednisolone. Reactions Weekly 1977, 22 (2023). https://doi.org/10.1007/s40278-023-47096-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-47096-5

Search

Navigation